Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8473210 | 0.84 | ATM (0.47) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL8473822 | 0.75 | KMT2A (0.37) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL25707806 | 0.74 | CA12 (0.53) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL8474906 | 0.74 | KMT2A (0.56) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL8475416 | 0.73 | MEN1 (0.59) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL16625790 | 0.72 | KMT2A (0.44) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL20366092 | 0.71 | DRD2 (0.40) | KMT2AMEN1 | |
| SCHEMBL25168083 | 0.71 | CA12 (0.48) | KMT2AMEN1KDM4EMAPTL3MBTL1 | |
| SCHEMBL13043939 | 0.69 | L3MBTL1 (0.40) | KMT2AMEN1KDM4EALDH1A1MAPT | |
| SCHEMBL20356793 | 0.69 | CA12 (0.46) | KDM4EMAPTL3MBTL1CA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005746-B2 | Molecular catalysts capable of catalyzing oxidation of hydrocarbons and method for oxidizing hydrocarbons | ACADEMIA SINICA (TW) | 2018-06-26 | — | — | US | disclosed |
| US-10005746-B2 | Molecular catalysts capable of catalyzing oxidation of hydrocarbons and method for oxidizing hydrocarbons | ACADEMIA SINICA (TW) | 2018-06-26 | — | — | US | disclosed |
| US-20150099876-A1 | Molecular Catalysts Capable of Catalyzing Oxidation of Hydrocarbons and Method for Oxidizing Hydrocarbons | NATIONAL TAIWAN UNIVERSITY (TW) | 2015-04-09 | — | — | US | disclosed |
| US-20150099876-A1 | Molecular Catalysts Capable of Catalyzing Oxidation of Hydrocarbons and Method for Oxidizing Hydrocarbons | NATIONAL TAIWAN UNIVERSITY (TW) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10005746-B2 | Molecular catalysts capable of catalyzing oxidation of hydrocarbons and method for oxidizing hydrocarbons | HMOX1, HMOX2, CYC1 | KMT2A 1312/4885MEN1 3681/4885KDM4E 2729/4885 |
| US-20150099876-A1 | Molecular Catalysts Capable of Catalyzing Oxidation of Hydrocarbons and Method for Oxidizing Hydrocarbons | HMOX1, HMOX2, CYC1 | KMT2A 1312/4885MEN1 3681/4885KDM4E 2729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.